JANX Research and Charts

JANX - Janux Therapeutics Inc Ordinary Shares (Healthcare: Biotechnology)

Projected Earnings Date: 2025-11-05 (Delayed quote data 2025-09-12)

Last 24.05	Change ⇓ -1.07 (-4.26%)	Volume 511,570
	Open 24.96	High 25.12	Low 24.02

8EMA (Daily) 24.06	40EMA (Daily) 24.26	50EMA (Daily) 24.47	STO (Daily) 59.261	MACD Hist (Daily) 0.304
8EMA (Weekly) 24.119	40EMA (Weekly) 29.89	50EMA (Weekly) 30.92	STO (Weekly) 32.012	MACD Hist (Weekly) 0.819


Company Profile
Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.